Cynosure Group’s CVS Health CVS Stock Holding History

Cynosure Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,319	Closed	-$382K	–	200
2026 Q1	$382K	Buy	+5,319	New	+$410K	0.05%	162
2022 Q3	–	Sell	-4,396	Closed	-$407K	–	32
2022 Q2	$407K	Buy	+4,396	New	+$429K	0.4%	26

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Cynosure Group's CVS Position: Q2 2026 in Review

Cynosure Group sold out of CVS Health (CVS) in Q2 2026, closing a stake of 5,319 shares — an estimated $382K sold.

Cynosure Group first reported a position in CVS in Q2 2022 and held it in 2 quarters. The position peaked at $407K in Q2 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Cynosure Group reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
Cynosure Group sold 5,319 CVS Health shares in Q2 2026, an estimated $382K.
Cynosure Group first reported a position in CVS Health in Q2 2022 and held it in 2 quarters.
Cynosure Group's CVS Health position peaked at $407K in Q2 2022.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Cynosure Group's 13F filing for Q2 2026, filed 5 Aug 2026.